The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
Open accessAbstract
Cancer cells reprogram their copper metabolism to adapt to adverse microenvironments, such as oxidative stress. The copper chelator elesclomol has been reported to have considerable anticancer efficacy, but the underlying mechanisms remain largely unknown. In this study, we found that elesclomol‐mediated copper overload inhibits colorectal cancer (CRC) both in vitro and in vivo . Elesclomol alone promotes the degradation of the copper transporter copper‐transporting ATPase 1 (ATP7A), which retards the proliferation of CRC cells. This property distinguishes it from several other copper chelators. Combinational treatment of elesclomol and copper leads to copper retention within mitochondria due to ATP7A loss, leading to reactive oxygen species accumulation, which in turn promotes the degradation of SLC7A11, thus further enhancing oxidative stress and consequent ferroptosis in CRC cells. This effect accounts for the robust antitumour activity of elesclomol against CRC, which can be reversed by the administration of antioxidants and ferroptosis inhibitors, as well as the overexpression of ATP7A. In summary, our findings indicate that elesclomol‐induced copper chelation inhibits CRC by targeting ATP7A and regulating ferroptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
Rae, T. D., Schmidt, P. J., Pufahl, R. A., Culotta, V. C., & V. O'Halloran, T. (1999) · Science · doi:10.1126/science.284.5415.805 · Cited by 1,629
Mechanisms for copper acquisition, distribution and regulation
Kim, B.-E., Nevitt, T., & Thiele, D. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.72 · Cited by 1,588
Metalloproteins and metal sensing
Waldron, K. J., Rutherford, J. C., Ford, D., & Robinson, N. J. (2009) · Nature · doi:10.1038/nature08300 · Cited by 1,269
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Friedmann Angeli, J. P., Krysko, D. V., & Conrad, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0149-1 · Cited by 1,259
Function and Regulation of Human Copper-Transporting ATPases
Lutsenko, S., Barnes, N. L., Bartee, M. Y., & Dmitriev, O. Y. (2007) · Physiological Reviews · doi:10.1152/physrev.00004.2006 · Cited by 864
Targeting copper in cancer therapy: ‘Copper That Cancer’
Denoyer, D., Masaldan, S., La Fontaine, S., & Cater, M. A. (2015) · Metallomics · doi:10.1039/c5mt00149h · Cited by 806
Mitochondrial metabolism promotes adaptation to proteotoxic stress
Tsvetkov, P., Detappe, A., Cai, K., Keys, H. R., Brune, Z., Ying, W., Thiru, P., Reidy, M., Kugener, G., Rossen, J., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0291-9 · Cited by 645
Transcriptome Profile of Human Colorectal Adenomas
Sabates-Bellver, J., Van der Flier, L. G., de Palo, M., Cattaneo, E., Maake, C., Rehrauer, H., Laczko, E., Kurowski, M. A., Bujnicki, J. M., Menigatti, M., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0267 · Cited by 496
Jorissen, R. N., Gibbs, P., Christie, M., Prakash, S., Lipton, L., Desai, J., Kerr, D., Aaltonen, L. A., Arango, D., Kruhøffer, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1431 · Cited by 437
Skrzypczak, M., Goryca, K., Rubel, T., Paziewska, A., Mikula, M., Jarosz, D., Pachlewski, J., Oledzki, J., & Ostrowsk, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013091 · Cited by 395
Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma
Tsang, T., Posimo, J. M., Gudiel, A. A., Cicchini, M., Feldser, D. M., & Brady, D. C. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0481-4 · Cited by 371
Nagai, M., Vo, N. H., Shin Ogawa, L., Chimmanamada, D., Inoue, T., Chu, J., Beaudette-Zlatanova, B. C., Lu, R., Blackman, R. K., Barsoum, J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.017 · Cited by 357
Metabolic crossroads of iron and copper
Collins, J. F., Prohaska, J. R., & Knutson, M. D. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00271.x · Cited by 356
Elesclomol induces cancer cell apoptosis through oxidative stress
Kirshner, J. R., He, S., Balasubramanyam, V., Kepros, J., Yang, C.-Y., Zhang, M., Du, Z., Barsoum, J., & Bertin, J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0298 · Cited by 353
Kaiser, S., Park, Y.-K., Franklin, J. L., Halberg, R. B., Yu, M., Jessen, W. J., Freudenberg, J., Chen, X., Haigis, K., Jegga, A. G., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-7-r131 · Cited by 338
(2009) · Metal ions in life sciences · doi:10.1039/1559-0836 · Cited by 332
Copper: Effects of Deficiency and Overload
Scheiber, I., Dringen, R., & Mercer, J. F. B. (2013) · Metal Ions in Life Sciences · doi:10.1007/978-94-007-7500-8_11 · Cited by 328
Hong, Y., Downey, T., Eu, K. W., Koh, P. K., & Cheah, P. Y. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9305-4 · Cited by 319
Wang, J., Luo, C., Shan, C., You, Q., Lu, J., Elf, S., Zhou, Y., Wen, Y., Vinkenborg, J. L., Fan, J., et al. (2015) · Nature Chemistry · doi:10.1038/nchem.2381 · Cited by 301
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
Aubert, L., Nandagopal, N., Steinhart, Z., Lavoie, G., Nourreddine, S., Berman, J., Saba-El-Leil, M. K., Papadopoli, D., Lin, S., Hart, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17549-y · Cited by 287
Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes
Setty, S. R. G., Tenza, D., Sviderskaya, E. V., Bennett, D. C., Raposo, G., & Marks, M. S. (2008) · Nature · doi:10.1038/nature07163 · Cited by 265
Shanbhag, V., Jasmer-McDonald, K., Zhu, S., Martin, A. L., Gudekar, N., Khan, A., Ladomersky, E., Singh, K., Weisman, G. A., & Petris, M. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817473116 · Cited by 233
Liao, Y., Zhao, J., Bulek, K., Tang, F., Chen, X., Cai, G., Jia, S., Fox, P. L., Huang, E., Pizarro, T. T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14698-y · Cited by 227
Copper toxicology, oxidative stress and inflammation using zebrafish as experimental model
Pereira, T. C. B., Campos, M. M., & Bogo, M. R. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3303 · Cited by 226
Ferroptosis Mediates Cuprizone-Induced Loss of Oligodendrocytes and Demyelination
Jhelum, P., Santos-Nogueira, E., Teo, W., Haumont, A., Lenoël, I., Stys, P. K., & David, S. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.1749-20.2020 · Cited by 214
Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer
Tsukamoto, S., Ishikawa, T., Iida, S., Ishiguro, M., Mogushi, K., Mizushima, H., Uetake, H., Tanaka, H., & Sugihara, K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2884 · Cited by 210
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Wu, P., Gao, W., Su, M., Nice, E. C., Zhang, W., Lin, J., & Xie, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641469 · Cited by 209
Self-citationO'Day, S., Gonzalez, R., Lawson, D., Weber, R., Hutchins, L., Anderson, C., Haddad, J., Kong, S., Williams, A., & Jacobson, E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1579 · Cited by 208
Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice
Guthrie, L. M., Soma, S., Yuan, S., Silva, A., Zulkifli, M., Snavely, T. C., Greene, H. F., Nunez, E., Lynch, B., De Ville, C., et al. (2020) · Science · doi:10.1126/science.aaz8899 · Cited by 195
Gaedcke, J., Grade, M., Jung, K., Camps, J., Jo, P., Emons, G., Gehoff, A., Sax, U., Schirmer, M., Becker, H., et al. (2010) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20811 · Cited by 187
Saporito-Magriñá, C., Musacco-Sebio, R., Andrieux, G., Kook, L., Orrego, M. T., Tuttolomondo, M. V., Desimone, M. F., Boerries, M., Borner, C., & Repetto, M. G. (2018) · Metallomics · doi:10.1039/c8mt00182k · Cited by 164
Blockhuys, S., Zhang, X., & Wittung-Stafshede, P. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910722117 · Cited by 153
16. Copper Complexes in Cancer Therapy
Denoyer, D., Clatworthy, S. A. S., & Cater, M. A. (2018) · De Gruyter eBooks · doi:10.1515/9783110470734-022 · Cited by 148
CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease
Southon, A. G., Szostak, K., Acevedo, K. M., Dent, K. A., Volitakis, I., Belaidi, A. A., Barnham, K. J., Crouch, P. J., Ayton, S., Donnelly, P. S., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14881 · Cited by 145
Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
Blackman, R. K., Cheung-Ong, K., Gebbia, M., Proia, D. A., He, S., Kepros, J., Jonneaux, A., Marchetti, P., Kluza, J., Rao, P. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029798 · Cited by 141
Lin, Y.-H., Friederichs, J., Black, M. A., Mages, J., Rosenberg, R., Guilford, P., Phillips, V., Thompson-Fawcett, M. W., Kasabov, N. K., Toro, T. T., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2734 · Cited by 131
Berkenblit, A., Eder, J. P., Ryan, D. P., Seiden, M. V., Tatsuta, N., Sherman, M. L., Dahl, T. A., Dezube, B. J., & Supko, J. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0964 · Cited by 117
Staub, E., Groene, J., Heinze, M., Mennerich, D., Roepcke, S., Klaman, I., Hinzmann, B., Castaños‐Vélez, E., Pilarsky, C. P., Mann, B., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0467-y · Cited by 97
Gaspar, C., Cardoso, J., Franken, P., Molenaar, L., Morreau, H. M., Möslein, G., Sampson, J. R., Boer, J. M., de Menezes, R. X., & Fodde, R. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070851 · Cited by 89
Wangpaichitr, M., Wu, C., You, M., Maher, J. C., Dinh, V., Feun, L. G., & Savaraj, N. (2009) · Cancers · doi:10.3390/cancers1010023 · Cited by 75
Qu, Y., Wang, J., Sim, M., Liu, B., Giuliano, A. E., Barsoum, J., & Cui, X. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0470-6 · Cited by 43
Reeves, P. G., & DeMars, L. C. S. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.04.004 · Cited by 32
Auman, J. T., Church, R. D., Lee, S., Watson, M. A., Fleshman, J. W., & McLeod, H. L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.05.010 · Cited by 31
Varadarajan, S., Okur, M. N., O’Bryan, J. P., Minshall, R. D., Fulton, D. J., Ushio‐Fukai, M., & Fukai, T. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00151.2020 · Cited by 30
Iron Injection Restores Brain Iron and Hemoglobin Deficits in Perinatal Copper-Deficient Rats
Pyatskowit, J. W., & Prohaska, J. R. (2008) · Journal of Nutrition · doi:10.1093/jn/138.10.1880 · Cited by 20
Cited by
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
Cuproptosis: mechanisms and links with cancers
Xie, J., Yang, Y., Gao, Y., & He, J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01732-y · Cited by 801
Copper metabolism in cell death and autophagy
Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023) · Autophagy · doi:10.1080/15548627.2023.2200554 · Cited by 701
Targeting cuproplasia and cuproptosis in cancer
Tang, D., Kroemer, G., & Kang, R. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00876-0 · Cited by 443
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Zheng, P., Zhou, C., Lu, L., Liu, B., & Ding, Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02485-0 · Cited by 352
Metadata
- Authors
- Gao, W., Huang, Z., Duan, J., Nice, E. C., Lin, J., & Huang, C.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2021-09-15
- Volume
- 15
- Issue
- 12
- Pages
- 3527-3544
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W3190196675
- Cited by
- 333
- References
- 48
- FWCI
- 28.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.